Inhibition of redundant Atg7-mediated lysosome-autophagy pathway augments the anti-cancer effects of a proteasome inhibitor in some human prostate cancer cells (Zhu et al., 2010), epidermal growth factor receptor-tyrosine kinase inhibitors in human lung cancer cells (Han et al., 2011), and cisplatin in human esophageal squamous cell carcinoma cells (Zhu et al., 2013). Here, ATG7 is linked to cancer.